BlackRock Group
IMI

BlackRock Group’s Intermolecular, Inc. IMI Stock Holding History

BlackRock Group’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-24,500
Closed -$135K – 2830
2013
Q3 		$135K Buy
+24,500
New +$154K ﹤0.01% 2563

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock Group's IMI Position: Q4 2013 in Review

BlackRock Group sold out of Intermolecular, Inc. (IMI) in Q4 2013, closing a stake of 24,500 shares — an estimated $135K sold.

BlackRock Group first reported a position in IMI in Q3 2013 and held it in 1 quarter. The position peaked at $135K in Q3 2013. 53 funds tracked by Wall St. Rank hold IMI as of Q4 2013.

  • BlackRock Group reported no remaining Intermolecular, Inc. position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 24,500 Intermolecular, Inc. shares in Q4 2013, an estimated $135K.
  • BlackRock Group first reported a position in Intermolecular, Inc. in Q3 2013 and held it in 1 quarter.
  • BlackRock Group's Intermolecular, Inc. position peaked at $135K in Q3 2013.
  • 53 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.